돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2076718생성일: 2026년 10월 26일

Hydrochloric Acid → 2,3-Dihydroxybutanedioic Acid

https://huagongshe.com/reaction/2076718

반응식

참여 물질

역할이름HCID투입량
반응물Hydrochloric AcidHCID 313—
반응물tert-Butyl methyl etherHCID 15413—
반응물ItraconazoleHCID 55283—
반응물L-Tartaric acidHCID 444305—
용매1,4-DioxaneHCID 31275—
생성물2,3-Dihydroxybutanedioic AcidHCID 875—
생성물Itraconazole hydrochlorideHCID 11434139—

반응 단계

Co-crystals of itraconazole HCl and tartaric acid were prepared. Approximately 212.7 mg of L-tartaric acid and 118 microL of 37% HCl were dissolved in 25 mL of hot dioxane. This solution was added to 1.0 g of cis-itraconazole dissolved in 50 mL of hot dioxane with stirring. The mixture was heated until a clear solution formed and was then allowed to cool to room temperature. Upon cooling, 50 mL tert-butyl methyl ether was added and the crystals were harvested by vacuum filtration on a Buchner funnel with #4 Whatman filter paper. The crystals were washed 3 times with 5 mL aliquots of cold tert-butyl methyl ether and left to air dry. Approximately 573 mg of a crystalline form of cis-itraconazole HCl-tartaric acid (1:1:0.5) co-crystal were obtained. (See FIGS. 20 and 21)

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07927613B2
출처 데이터셋uspto-grants-2011_04
ORD IDord-e7ffca1b8a794dc2afbb6d3f2ae1018f
출처 메모uspto-grants-2011_04